The 894G > T (Glu298Asp) Variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline

NeuroMolecular Medicine

Volumn 13, Issue 3, 2011, Pages 167-174

  Ferlazzo, Nadia ^a   Gorgone, Gaetano ^b   Caccamo, Daniela ^a   Currò, Monica ^a   Condello, Salvatore ^a   Pisani, Francesco ^a   Vernieri, Fabrizio ^c   Rossini, Paolo Maria ^c   Ientile, Riccardo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Alzheimer's disease; Cognitive decline; ENOS; Hyperhomocysteinemia; MTHFR; SNPs; Vascular dementia

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; HOMOCYSTEINE;

AGED; AMINO ACID BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MUTATOR GENE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84855895652     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-011-8148-8     Document Type: Article

References (47)

1. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F., et al. (2008). Alzheimer disease cooperative study. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial. The Journal of the American Medical Association, 300, 1774-1783.
2. Babiloni, C., Bosco, P., Ghidoni, R., Del Percio, C., Squitti, R., Binetti, G., et al. (2007). Homocysteine and electroencephalo-graphic rhythms in Alzheimer disease: A multicentric study. Neuroscience, 145, 942-954. (Pubitemid 46454356)
3. Botto, N., Andreassi, M. G., Manfredi, S., Masetti, S., Cocci, F., Colombo, M. G., et al. (2003). Genetic polymorphisms in folate and Hcy metabolism as risk factors for DNA damage. European Journal of Human Genetics, 11, 671-678. (Pubitemid 37160988)
4. Brown, K. S., Kluijtmans, L. A. J., Young, I. S., Woodside, J., Yarnell, J. W. G., McMaster, D., et al. (2003). Genetic evidence that nitric oxide modulates Hcy. The eNOS 894TT genotype is a risk factor for hyperhomocysteinemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1014-1020.
5. Caccamo, D., Condello, S., Gorgone, G., Crisafulli, G., Belcastro, V., Gennaro, S., et al. (2004). Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular Medicine, 6, 117-126. (Pubitemid 41265781)
6. Caccamo, D., Gorgone, G., Currò, M., Parisi, G., Di Iorio, W., Menichetti, C., et al. (2007). Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. Neuromolecular Medicine, 9, 249-254. (Pubitemid 350129699)
7. Chrysohoou, C., Panagiotakos, D. B., Pitsavos, C., Antoniades, C., Skoumas, J., Brown, M., et al. (2004). Evidence for association between endothelial nitric oxide synthase gene polymorphism (894G>T) and inflammatory markers: The ATTICA study. American Heart Journal, 148, 733-738. (Pubitemid 39349396)
8. Colombo, M. G., Andreassi, M. G., Paradossi, U., Botto, N., Manfredi, S., Masetti, S., et al. (2002). Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298- > Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart, 87, 525-528. (Pubitemid 34547974)
9. Colombo, M. G., Paradossi, U., Andreassi, M. G., Botto, N., Manfredi, S., Masetti, S., et al. (2003). Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clinical Chemistry, 49, 389-395. (Pubitemid 36250199)
10. Crawford, F., Freeman, M., Abdullah, L., Schinka, J., Gold, M., Duara, R., et al. (2000). No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States. Annals of Neurology, 47, 687. (Pubitemid 30261915)
11. Datta, S., Pal, S. K., Mazumdar, H., Bhandari, B., Bhattacherjee, S., & Pandit, S. (2009). Homocysteine and cerebrovascular accidents. Journal of the Indian Medical Association, 107, 345-346.
12. Dayal, S., Arning, E., Bottiglieri, T., Böger, R. H., Sigmund, C. D., Faraci, F. M., et al. (2004). Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke, 35, 1957-1962. (Pubitemid 38971883)
13. Fatini, C., Sofi, F., Gori, A. M., Sticchi, E., Marcucci, R., Lenti, M., et al. (2005). Endothelial nitric oxide synthase -786T > C, but not 894G>T and 4a4b, polymorphism influences plasma Hcy concentrations in persons with normal vitamin status. Clinical Chemistry, 51, 1159-1164.
14. Fuh, J. L. (2010). Homocysteine, cognition and brain white matter hyperintensities. Acta neurologica Taiwanica, 19, 150-152.
15. Giusti, B., Gori, A. M., Marcucci, R., Sestini, I., Saracini, C., Sticchi, E., et al. (2007). Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility. PLoS One, 2, 495.
16. Gorgone, G., Caccamo, D., Pisani, L. R., Currò, M., Parisi, G., Oteri, G., et al. (2009a). Hyperhomocysteinemia in patients with epilepsy: Does it play a role in the pathogenesis of brain atrophy? A preliminary report. Epilepsia, 50, 33-36.
17. Gorgone, G., Ursini, F., Altamura, C., Bressi, F., Tombini, M., Curcio, G., et al. (2009b). Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment. Atherosclerosis, 206, 309-313.
18. Guidi, I., Galimberti, D., Venturelli, E., Lovati, C., Del Bo, R., Fenoglio, C., et al. (2005). Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiology of Aging, 26, 789-794. (Pubitemid 40249480)
19. Heil, S. G., Den Heijer, M., Ven Der Rijt-Pisa, B. J. M., Kluijtmans, L. A. J., & Blom, H. J. (2004). The 894G>T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels. Journal of Thrombosis and Haemostasis, 2, 750-753. (Pubitemid 40185713)
20. Higuchi, S., Ohta, S., Matsushita, S., Matsui, T., Yuzuriha, T., Urakami, K., et al. (2000). NOS3 polymorphism not associated with Alzheimer's disease in Japanese. Annals of Neurology, 48, 685.
21. Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analyses: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.
22. Iadecola, C., & Davisson, R. L. (2008). Hypertension and cerebro-vascular dysfunction. Cell Metabolism, 7, 476-484.
23. Ientile, R., Curro', M., Ferlazzo, N., Condello, S., Caccamo, D., & Pisani, F. (2010). Homocysteine, vitamin determinants and neurological diseases. Frontiers in Bioscience, 2, 359-372.
24. Kalaria, R. (2002). Similarities between Alzheimer's disease and vascular dementia. Journal of the Neurological Sciences, 15, 29-34. (Pubitemid 35287372)
25. Kerkeni, M., Addad, F., Chauffert, M., Myara, A., Ben Farhat, M., Miled, A., et al. (2006). Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clinical Chemistry, 52, 53-58. (Pubitemid 43032466)
26. Khachaturian, A. S., Zandi, P. P., Lyketsos, C. G., Hayden, K. M., Skoog, I., Norton, M. C., et al. (2006). Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Archives of Neurolology, 63, 686-692.
27. Kuzkaya, N., Weissmann, N., Harrison, D. G., & Dikalov, S. (2003). Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncouplingendothelial nitric-oxide synthase. The Journal of Biological Chemistry, 278, 22546-22554. (Pubitemid 36830310)
28. Laukka, E. J., Fratiglioni, L., & Bäckman, L. (2010). The influence of vascular disease on cognitive performance in the preclinical and early phases of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 29, 498-503.
29. Launer, L. J. (2002). Demonstrating the case that AD is a vascular disease: Epidemiologic evidence. Ageing Research Reviews, 1(1), 61-67.
30. Marlatt, M. W., Lucassen, P. J., Perry, G., Smith, M. A., & Zhu, X. (2008). Alzheimer's disease: Cerebrovascular dysfunction, oxi-dative stress, and advanced clinical therapies. Journal of Alzheimer's Disease, 15, 199-210.
31. Mattson, M. P., & Shea, T. B. (2003). Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neurosciences, 26, 137-146. (Pubitemid 36183675)
32. Middleton, L. E., & Yaffe, K. (2009). Promising strategies for the prevention of dementia. Archives of Neurology, 66, 1210-1215.
33. Monastero, R., Cefalù, A. B., Camarda, C., Buglino, C. M., Mannino, M., Barbagallo, C. M., et al. (2003). No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease. Neuroscience Letters, 341, 229-232. (Pubitemid 36403770)
34. Ott, M., Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis, 12, 913-922. (Pubitemid 46653300)
35. Oudi, M. E., Aouni, Z., Mazigh, C., Khochkar, R., Gazoueni, E., Haouela, H., et al. (2010). Homocysteine and markers of inflammation in acute coronary syndrome. Experimental and Clinical Cardiology, 15, 25-28.
36. Owuor, E. D., & Kong, A. N. (2002). Antioxidants and oxidants regulated signal transduction pathways. Biochemical Pharmacology, 64, 765-770. (Pubitemid 35238028)
37. Pacher, P., Beckman, J. S., & Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiological Reviews, 87, 315-424. (Pubitemid 46217686)
38. Peila, R., White, L. R., Masaki, K., Petrovitch, H., & Launer, L. J. (2006). Reducing the risk of dementia: Efficacy of long-term treatment of hypertension. Stroke, 37, 1165-1170. (Pubitemid 43731856)
39. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303-308. (Pubitemid 29120227)
40. Sánchez-Guerra, M., Combarros, O., Alvarez-Arcaya, A., Mateo, I., Berciano, J., González-García, J., et al. (2001). The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 70, 566-567. (Pubitemid 32269708)
41. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476-483. (Pubitemid 34441738)
42. Sharma, P., Senthilkumar, R. D., Brahmachari, V., Sundaramoorthy, E., Mahajan, A., Sharma, A., et al. (2006). Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids in Health and Disease, 5, 1.
43. Tesauro, M., Thompson, W. C., Rogliani, P., Qi, L., Chaudhary, P. P., & Moss, J. (2000). Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proceedings of the National Academy of Science, 97, 2832-2835. (Pubitemid 30159257)
44. Topal, G., Brunet, A., Millanvoye, E., Boucher, J. L., Rendu, F., Devynck, M. A., et al. (2004). Homocysteine induces oxidative stress by uncoupling of no synthase activity through reduction of tetrahydrobiopterin. Free Radical Biology and Medicine, 36, 1532-1541. (Pubitemid 38746561)
45. Veldman, B. A., Spiering, W., Doevendans, P. A., Vervoort, G., Kroon, A. A., & de Leeuw, P. W. (2002). The Glu298Asp polymorphisms of the eNOS gene as a determinant of the baseline production of nitric oxide. Journal of Hypertension, 20, 2023-2027. (Pubitemid 35305500)
46. Winkelmayer, W. C., Huber, A., Wagner, O. F., Horl, W. H., Sunder Plassmann, G., & Fodinger, M. (2005). Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney International, 67, 1980-1985. (Pubitemid 40577735)
47. Zambrzycka, A., Cakała, M., & Kamińska, M. (2003). Transition metal ions significantly decrease phospholipase C activity degrading phosphatidylinositol-4,5-bisphosphate in the brain cortex. Polish Journal of Pharmacology, 55, 915-917. (Pubitemid 37540890)